ArticleSleep & breathing = Schlaf & Atmung2025
Real world characteristics of central sleep apnea: a review of 29,000 consecutive patients undergoing polysomnography.
Article in Sleep & breathing = Schlaf & Atmung, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A pilot study to assess a novel screening questionnaire for central sleep apnea in patients undergoing overnight diagnostic polysomnography.Sleep & breathing = Schlaf & Atmung · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
purposeThe characteristics of central sleep apnea (CSA) in real-world sleep referral populations remain poorly understood. We used the electronic health record of a large health system to understand the prevalence and risk factors for CSA among patients referred for sleep evaluation.
methodsWe reviewed the records of 29,803 patients who underwent diagnostic polysomnography at six sleep laboratories over 14 years. A validated algorithm was used to extract polysomnographic results. CSA was defined as having an apnea hypopnea index (AHI) ≥ 5, a central apnea index ≥ 5, and a central apnea index > obstructive apnea index, while obstructive sleep apnea (OSA) was defined as AHI ≥ 5, obstructive apnea index ≥ 5, and obstructive apnea index > central apnea index.
resultsA total of 583 patients had CSA (2.0% of overall cohort and 5.5% of those with AHI ≥ 5). Compared to those with OSA, older age and male sex were strong risk factors for CSA. The comorbidities most strongly associated with CSA included prior myocardial infarction and atrial fibrillation with adjusted odds ratios of 1.88 (95% confidence interval 1.28-2.74), and 1.85 (1.43-2.38). The prevalence of CSA in these groups was 7.1%, and 5.8% respectively. Of note, the importance of risk factors varied by sex.
conclusionCSA was identified in 2.0% of patients undergoing diagnostic polysomnography in routine clinical practice, with risk varying substantially by demographics and comorbidities. Greater recognition of CSA risk can lead to more thoughtful evaluation to ensure accurate diagnosis and appropriate treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.